State Street SPDR S&P Pharmaceuticals ETF (XPH) closed at $64.75 on November 6, 2026, up 3.4% from the previous close, on volume of 166,926 shares (30-day average 229,664).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
No headlines found.
No press releases found.
No news found.
State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "Index"), the Fund employs a sampling strategy, which means that the Fund is not required to purchase all of the securities represented in the Index. The Index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The S&P TMI is designed to track the broad U.S. equity market. The pharmaceuticals segment of the S&P TMI comprises the Pharmaceuticals sub-industry. The Index is one of twenty-one (21) of the S&P Select Industry Indices (the "Select Industry Indices"), each designed to measure the performance of a narrow sub-industry or group of sub-industries determined based on the Global Industry Classification Standard ("GICS").
State Street SPDR S&P Pharmaceuticals ETF trades on the ARCA stock market under the symbol XPH.
As of November 6, 2026, XPH stock price climbed to $64.75 with 166,926 million shares trading.
XPH has a beta of 0.72, meaning it tends to be less sensitive to market movements. XPH has a correlation of 0.18 to the broad based SPY ETF.
XPH has a market cap of $482.40 million. This is considered a Small Cap stock.
In the last 3 years, XPH traded as high as $74.35 and as low as $34.67.
XPH has outperformed the market in the last year with a price return of +33.8% while the SPY ETF gained +10.8%. However, in the short term, XPH had mixed performance relative to the market. It has underperformed in the last 3 months, returning -7.9% vs -4.1% return in SPY. But in the last 2 weeks, XPH shares have fared better than the market returning +3.3% compared to SPY -3.2%.
XPH support price is $61.54 and resistance is $63.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XPH shares will trade within this expected range on the day.
